简体中文

Newsroom

News November 17, 2018

QuaCell signed strategic cooperation agreement with Sartorius

On November 16, 2018, the 13th Zhongshan Forum for Health and Development, co-sponsored by the Government of Zhongshan City and twelve first-level academic societies, was officially opened at the Hilton Hotel Zhongshan.
Learn More
News November 14, 2018

Finalist National-Quacell Biotechnology won the Second place in the Biomedical Industry Finals of the 7th China Innovation and Entrepreneurship Competition (Guangdong Division)

Yesterday, the 7th China Innovation and Entrepreneurship Competition (Guangdong Division) and the 6th“Pearl Angel Cup” Technology Innovation and Entrepreneurship Competition finals were held in Guangzhou, South China, New Materials Innovation Park.
Learn More
News September 3, 2018

Awarded the Fifth Whampoa Cup "Creating Youth" Guangdong Innovation and Entrepreneurship Competition and the second prize of the first Guangdong-Hong Kong-Macao Greater Bay Area Youth Innovation and Entrepreneurship Group

QuaCell Biotechnology relies on "core materials for biological drug research and development and production --the CD medium industrialization project, the core material for biopharmaceutical R&D and production, advanced to the finals in the Fifth "Creating Youth" Guangdong Innovation and Entrepreneurship Competition in the Whampoa Cup 2018 and the first Guangdong-Hong Kong-Macao Greater Bay Area Youth Innovation and Entrepreneurship Competition. Second Prize in the Start-up Group".
Learn More
News July 1, 2018

Obtained pre-A round of investment from 'National Venture Capital', 'Xiangshang Investment', 'Jiangmen Taikang' and other institutions

QuaCell Biotechnology completed the pre-A round of financing and obtained tens of millions of investment from Guangdong National Innovation Investment Management Co., Ltd. ("National Venture Capital"), Zhongshan Xiangshang Investment Management Co., Ltd. ("Xiangshang Investment")and Jiangmen Taikang Investment Partnership Co., Ltd. ("Jiangmen Taikang").
Learn More
News May 1, 2018

CHO CD02, CHO CD04, and CHO Feed02 were launched

QuaCell Biotechnology’s three new products were officially launched, namely CHO CD02, CHO CD04, and CHO Feed02.
Learn More
News April 13, 2018

QuaCell Biotechnology was registered and established

QuaCell Biotechnology Co., Ltd. (QuaCell Biotechnology) was registered and established, engaged in the field of biotechnology and biopharmaceutical product research and development production and sales.
Learn More
News April 2, 2018

Completed a seed round of investment from Queshan Investment

Queshan Investment is a professional investment institution focusing on PE equity investment and management.
Learn More
News January 5, 2018

Quacell Biotechnology and India Samas reached a CRO service cooperation

Two sides will conduct comprehensive cooperation on host cell lines, culture media, CRO services and other aspects in the six monoclonal antibody projects. Samarth Group, founded in 1963, is one of the top ten pharmaceutical groups in India.
Learn More